1. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine
    Hua Luo et al, 2019, Chinese Medicine CrossRef
  2. Pharmacological basis of tanshinone and new insights into tanshinone as a multitarget natural product for multifaceted diseases
    Zhibei Li et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  3. Tanshinone IIA Inhibits Epithelial-to-Mesenchymal Transition Through Hindering β-Arrestin1 Mediated β-Catenin Signaling Pathway in Colorectal Cancer
    Qing Song et al, 2020, Frontiers in Pharmacology CrossRef
  4. Tanshinone Suppresses Arecoline-Induced EpithelialMesenchymal Transition in Oral Submucous Fibrosis by Epigenetically Reactivating the p53 Pathway
    Lian Zheng et al, 2018, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
  5. Mechanisms of Tanshinone II a inhibits malignant melanoma development through blocking autophagy signal transduction in A375 cell
    Xiaojing Li et al, 2017, BMC Cancer CrossRef
  6. Neuroprotective effect of tanshinone IIA weakens spastic cerebral palsy through inflammation, p38MAPK and VEGF in neonatal rats
    Wen‑Luo Zhang et al, 2017, Molecular Medicine Reports CrossRef
  7. Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science
    Yuening Xiang et al, 2019, Cancer Medicine CrossRef
  8. Tanshinone IIA: A Review of its Anticancer Effects
    Zhong‐ying Fang et al, 2021, Frontiers in Pharmacology CrossRef
  9. Tanshinone IIA: New Perspective on the Anti-Tumor Mechanism of A Traditional Natural Medicine
    Wenfeng Zhang et al, 2022, The American Journal of Chinese Medicine CrossRef
  10. Tanshinone IIA induces apoptosis via inhibition of Wnt/β-catenin/MGMT signaling in AtT-20 cells
    Zong-Yang Li et al, 2017, Molecular Medicine Reports CrossRef
  11. Helveticoside Exhibited p53-dependent Anticancer Activity Against Colorectal Cancer
    Na An et al, 2020, Archives of Medical Research CrossRef
  12. An overview of the anti-cancer actions of Tanshinones, derived from Salvia miltiorrhiza (Danshen)
    Irum Naz et al, 2020, Exploration of Targeted Anti-tumor Therapy CrossRef
  13. Inhibition of EGFR Signaling and Activation of Mitochondrial Apoptosis Contribute to Tanshinone IIA-Mediated Tumor Suppression in Non-Small Cell Lung Cancer Cells


    Feng Gao et al, 2020, OncoTargets and Therapy CrossRef
  14. Tanshinone‑IIA attenuates the deleterious effects of oxidative stress in osteoporosis through the NF‑κB signaling pathway
    Shaowen Zhu et al, 2018, Molecular Medicine Reports CrossRef
  15. Recent Research Progress (2015–2021) and Perspectives on the Pharmacological Effects and Mechanisms of Tanshinone IIA
    Chenhui Zhong et al, 2021, Frontiers in Pharmacology CrossRef
  16. Anticancer Activity of Salvia miltiorrhiza and Its Secondary Metabolites
    Ching-Fen Wu et al, 2017, Salvia Biotechnology CrossRef
  17. Tanshinones and their Derivatives: Heterocyclic Ring-Fused Diterpenes of Biological Interest
    Arturo Estolano-Cobián et al, 2021, Mini-Reviews in Medicinal Chemistry CrossRef
  18. Targeting Aurora B kinase with Tanshinone IIA suppresses tumor growth and overcomes radioresistance
    Ming Li et al, 2021, Cell Death & Disease CrossRef
  19. Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases


    Rui Guo et al, 2020, Drug Design, Development and Therapy CrossRef
  20. Neuroprotective effect of tanshinone IIA against neuropathic pain in diabetic rats through the Nrf2/ARE and NF-κB signaling pathways
    Fa-Bo Feng et al, 2018, The Kaohsiung Journal of Medical Sciences CrossRef
  21. Danshen improves survival of patients with colon cancer and dihydroisotanshinone I inhibit the proliferation of colon cancer cells via apoptosis and skp2 signaling pathway
    Yin-Yin Lin et al, 2017, Journal of Ethnopharmacology CrossRef
  22. Antitumor and radiosensitizing synergistic effects of apigenin and cryptotanshinone against solid Ehrlich carcinoma in female mice
    Amina M Medhat et al, 2017, Tumor Biology CrossRef